Finance

Beta
Lists
CRVO:NASDAQ
CervoMed Inc
$3.15
-9.74%
(-0.34) 1D
$3.16
+0.32% (+0.0100)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVO...
Open
$3.39
High
$3.40
Low
$3.15
Mkt. cap
42.61M
Avg. vol.
11.19M
Volume
584.32K
52-wk high
$13.13
52-wk low
$2.15
EPS
-$3.27
Beta
-0.68
Shares outstanding
13.53M
No. of employees
15
Open
$3.39
High
$3.40
Low
$3.15
Mkt. cap
42.61M
Avg. vol.
11.19M
Volume
584.32K
52-wk high
$13.13
52-wk low
$2.15
EPS
-$3.27
Beta
-0.68
Shares outstanding
13.53M
No. of employees
15
News stories
From sources across the web
About CervoMed Inc
CEO-
Employees15
Founded1995
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitecervomed.com
Analyst ratings
Based on 5 analysts giving stock ratings to CRVO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CRVO in the last 3 months.
Highest
Current $3.15
$27.00 (+757.14%)
Average
$20.40 (+547.62%)
Lowest
$9.00 (+185.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$25.00
+693.7%
06/25/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$9.00
+185.7%
06/12/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$27.00
+757.1%
05/19/2026
Boris Peaker
JonesTrading
Buy
Maintained
$20.00
+534.9%
05/18/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$21.00
+566.7%
05/17/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+534.9%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.76M
322.57K
8.73K
-
Cost of goods sold
5.11M
6.04M
5.83M
5.01M
Cost of revenue
5.11M
6.04M
5.83M
5.01M
Research and development expenses
-
-
-
126.71K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.27M
2.33M
2.51M
2.98M
Operating expense
3.27M
2.33M
2.51M
3.10M
Total operating expenses
8.37M
8.37M
8.34M
8.11M
Operating income
-6.62M
-8.04M
-8.33M
-8.11M
Other non operating income
-10.26K
-1.23K
3.29K
-1.02K
EBT including unusual items
-6.26M
-7.73M
-8.09M
-7.96M
EBT excluding unusual items
-6.26M
-7.73M
-8.09M
-7.96M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.26M
-7.73M
-8.09M
-7.96M
Net profit margin
-356.05%
-2,395.34%
-92,680.38%
-
Earnings per share
-0.70
-0.84
-0.88
-0.86
Interest and investment income
368.13K
318.79K
240.94K
147.39K
Interest expense
-
-
-
-
Net interest expenses
368.13K
318.79K
240.94K
147.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer